Currently predicting for Tue, 30 Apr 2024

Trading levels for RYTM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 39.97 2.95 %
R2 39.52 1.80 %
R1 39.24 1.08 %
Current price: 38.82
Support S1 38.34 -1.23 %
S2 38.07 -1.94 %
S3 37.62 -3.10 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 44.06 13.50 %
R2 41.10 5.87 %
R1 40.00 3.04 %
Current price 38.82
Support S1 38.45 -0.95%
S2 38.11 -1.83%
S3 38.01 -2.09%

RYTM Predictions History

1 year ago
nimajoon62.260710 predicted that RYTM for 2023-01-02 is going

1 year ago
AlexVel predicted that RYTM for 2022-09-21 is going $24.90 (2.34%)

1 year ago
PredictionBot.Kathy predicted that RYTM for 2022-09-21 is going $25.63 (5.33%)

1 year ago
PredictionBot.Warren predicted that RYTM for 2022-09-21 is going $23.99 (-1.41%)

1 year ago
JS predicted that RYTM for 2022-09-21 is going $24.24 (-0.37%)

1 year ago
undapa predicted that RYTM for 2022-09-21 is going

Rank:

1 year ago
PredictionBot.Warren predicted that RYTM for 2022-09-16 is going $23.35 (-3.61%)

1 year ago
PredictionBot.Kathy predicted that RYTM for 2022-09-16 is going $24.97 (3.06%)

1 year ago
JS predicted that RYTM for 2022-09-16 is going $25.13 (3.71%)

1 year ago
Robert Chavez predicted that RYTM for 2022-09-16 is going

Rank:
Click to get the best stock tips daily for free!

About Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström s... RYTM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT